Total Payments
$4,281
2024 Payments
$422.73
Companies
15
Transactions
254
Medicare Patients
77
Medicare Billing
$109,138
Payment Breakdown by Category
Food & Beverage$4,088 (95.5%)
Education$192.48 (4.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,088 | 252 | 95.5% |
| Education | $192.48 | 2 | 4.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $889.91 | 63 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $793.45 | 46 | $0 (2024) |
| Alkermes, Inc. | $576.26 | 29 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $554.33 | 25 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $533.25 | 33 | $0 (2024) |
| Lundbeck LLC | $373.80 | 24 | $0 (2024) |
| ITI, Inc. | $176.32 | 11 | $0 (2022) |
| Allergan, Inc. | $104.96 | 8 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $56.00 | 3 | $0 (2021) |
| Shire North American Group Inc | $52.44 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $422.73 | 21 | Janssen Pharmaceuticals, Inc ($137.03) |
| 2023 | $606.55 | 30 | Otsuka America Pharmaceutical, Inc. ($221.87) |
| 2022 | $649.56 | 41 | Alkermes, Inc. ($170.17) |
| 2021 | $1,037 | 60 | Teva Pharmaceuticals USA, Inc. ($296.78) |
| 2020 | $400.06 | 23 | Neurocrine Biosciences, Inc. ($144.36) |
| 2019 | $538.83 | 36 | Janssen Pharmaceuticals, Inc ($145.60) |
| 2018 | $372.56 | 27 | Janssen Pharmaceuticals, Inc ($129.57) |
| 2017 | $253.38 | 16 | Otsuka America Pharmaceutical, Inc. ($128.02) |
All Payment Transactions
254 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/29/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Central Nervous System | ||||||
| 12/09/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/18/2024 | Janssen Pharmaceuticals, Inc | INVEGA (Drug) | Food and Beverage | In-kind items and services | $30.13 | General |
| Category: Neuroscience | ||||||
| 10/25/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: CNS | ||||||
| 09/16/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $15.26 | General |
| Category: PSYCHIATRY | ||||||
| 08/29/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $27.85 | General |
| Category: Neuroscience | ||||||
| 08/25/2024 | Janssen Pharmaceuticals, Inc | INVEGA (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Neuroscience | ||||||
| 07/22/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $18.59 | General |
| Category: PSYCHIATRY | ||||||
| 07/19/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: Neuroscience | ||||||
| 07/15/2024 | Janssen Pharmaceuticals, Inc | INVEGA (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Neuroscience | ||||||
| 06/03/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $17.57 | General |
| Category: PSYCHIATRY | ||||||
| 05/07/2024 | Janssen Pharmaceuticals, Inc | INVEGA (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: Neuroscience | ||||||
| 04/30/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $16.47 | General |
| Category: PSYCHIATRY | ||||||
| 03/27/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Central Nervous System | ||||||
| 03/15/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $18.50 | General |
| Category: PSYCHIATRY | ||||||
| 03/06/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Neurology | ||||||
| 02/23/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: CNS | ||||||
| 02/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Central Nervous System | ||||||
| 01/31/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Central Nervous System | ||||||
| 01/05/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Central Nervous System | ||||||
| 11/17/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: PSYCHIATRY | ||||||
| 11/02/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Neuroscience | ||||||
| 10/27/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Neuroscience | ||||||
| 10/26/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 33 | 388 | $651,500 | $57,026 |
| 2022 | 3 | 44 | 348 | $511,000 | $52,112 |
Total Patients
77
Total Services
736
Medicare Billing
$109,138
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90868 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | Office | 2023 | 19 | 374 | $646,600 | $54,738 | 8.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $4,900 | $2,288 | 46.7% |
| 90868 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | Office | 2022 | 13 | 317 | $472,500 | $47,089 | 10.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 18 | 18 | $6,000 | $2,876 | 47.9% |
| 90867 | Treatment using magnetic field to stimulate nerve cells in brain, initial delivery and management | Office | 2022 | 13 | 13 | $32,500 | $2,147 | 6.6% |
About Chance Mcinnis
Chance Mcinnis is a Psychiatry healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2013. The National Provider Identifier (NPI) number assigned to this provider is 1962845768.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Chance Mcinnis has received a total of $4,281 in payments from pharmaceutical and medical device companies, with $422.73 received in 2024. These payments were reported across 254 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($4,088).
As a Medicare-enrolled provider, Mcinnis has provided services to 77 Medicare beneficiaries, totaling 736 services with total Medicare billing of $109,138. Data is available for 2 years (2022–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Tyler, TX
- Active Since 04/10/2013
- Last Updated 10/01/2018
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1962845768
Products in Payments
- ABILIFY MAINTENA (Drug) $788.90
- INGREZZA (Drug) $554.33
- INVEGA SUSTENNA (Drug) $543.67
- ARISTADA (Drug) $521.15
- AUSTEDO (Drug) $275.61
- REXULTI (Drug) $270.48
- CAPLYTA (Drug) $176.32
- VRAYLAR (Drug) $144.73
- INVEGA TRINZA (Drug) $130.42
- SPRAVATO (Drug) $117.19
- ABILIFY ASIMTUFII (Drug) $107.87
- INVEGA (Drug) $98.63
- Austedo XR (Drug) $85.21
- UZEDY (Drug) $68.96
- LATUDA (Drug) $56.00
- Aristada 441 mg (Drug) $55.11
- Auvelity (Drug) $44.51
- HETLIOZ (Drug) $41.50
- VYVANSE (Drug) $39.23
- PERSERIS (Drug) $29.47
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Tyler
Gary Wilson, Md, MD
Psychiatry — Payments: $4,403
Psychiatry $4,403
David Danly, Md, MD
Psychiatry — Payments: $4,150
Psychiatry $4,150
Dr. Douglas Ghrist, M.d, M.D
Psychiatry — Payments: $1,644
Psychiatry $1,644
Igal Tarash, Do Md Emba, DO MD EMBA
Psychiatry — Payments: $734.11
Psychiatry $734.11
Phyllis Ramirez, Md, MD
Psychiatry — Payments: $712.87
Psychiatry $712.87
Andrew Oshiro, Md, MD
Psychiatry — Payments: $635.43
Psychiatry $635.43